IPIC (IPIC) Stock Price & Analysis
IPIC (IPIC) rose 0.00% to USD 0 as of June 10, 2026 at 03:28 UTC, according to Nexqual real-time market data.
IPIC last closed at USD 0; the session ranged USD 0–0 on volume of 424 shares. Market capitalization is $714, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 03:28 UTC.
Key Statistics (as of June 10, 2026 at 03:28 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 424 shares |
| Market Cap | $714 |
| Exchange | PNK |
Technical Analysis (IPIC)
Nexqual's technical model rates IPIC "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:28 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (IPIC)
Wall Street analysts rate IPIC "None", per Nexqual as of June 10, 2026 at 03:28 UTC.
| Consensus Rating | None |
|---|
Earnings (IPIC)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2019-03-31 | USD -1.25 vs est -0.99 ▼ miss |
| 2018-12-31 | USD -0.24 vs est -0.78 ▲ beat |
| 2018-09-30 | USD -1 vs est -0.81 ▼ miss |
| 2018-06-30 | USD -0.43 vs est -0.92 ▲ beat |
Source: Nexqual, June 10, 2026 at 03:28 UTC.
Financials & Fundamentals (IPIC)
| Total Revenue | $139.88M |
|---|---|
| Revenue Growth (YoY) | -21.90% |
| Gross Margin | +27.45% |
| Operating Margin | -32.97% |
| Profit Margin | -18.68% |
| Current Ratio | 0.45 |
| Total Cash | $3.56M |
| Total Debt | $203.57M |
| Free Cash Flow | $-41.29M |
Source: Nexqual, June 10, 2026 at 03:28 UTC.
Financial Health Score (IPIC)
Nexqual rates IPIC's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 03:28 UTC.
| Growth | Solid — Revenue +6% YoY (annual) |
|---|---|
| Profitability | Weak — Gross margin 27%, operating -33% |
| Balance Sheet | Mixed — $4M cash vs $204M debt |
| Cash Flow | Weak — FCF negative: -$41M, burning cash |
| Efficiency | Mixed — No data |
Ownership (IPIC)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 7.14M |
| Float | 7.11M |
| Short % of Float | +17.23% |
Source: Nexqual, June 10, 2026 at 03:28 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MAGN | Magnera Corporation | USD 11.7 | ▲ 4.28% |
| ERGO | Entia Biosciences Inc. | USD 0 | ▲ 0% |
| ICCC | ImmuCell Corporation | USD 9.77 | ▲ 1.66% |
| CVAS | CREATIVE VISTAS INC | USD 0 | ▲ 0% |
| HMGN | HEMAGEN DIAGNOSTICS INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:28 UTC. This page is informational and not investment advice.